Concepedia

Philip E. Brandish

PE

28

Publications

2.6K

Citations

21

H-Index

1996

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

University of Michigan

Howard Hughes Medical Institute

WuXi AppTec (China)

Philip E. Brandish is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, pharmacology, and drug discovery.

ORCID

Top concepts

Publications per year

1996–2024

28

Publications

28

A molecular basis for nitric oxide sensing by soluble guanylate cyclase

Yunde Zhao, Philip E. Brandish, David P. Ballou et al. · Proceedings of the National Academy of Sciences · 1999 · 322 citations

N-desmethylclozapine, an allosteric agonist at muscarinic 1 receptor, potentiates N-methyl- <scp>d</scp> -aspartate receptor activity

Cyrille Sur, Pierre Mallorga, Marion Wittmann et al. · Proceedings of the National Academy of Sciences · 2003 · 288 citations · Full text

Cancer-Associated Fibroblasts Promote Immunosuppression by Inducing ROS-Generating Monocytic MDSCs in Lung Squamous Cell Carcinoma

Handan Xiang, Carlo P. Ramil, Josephine Hai et al. · Cancer Immunology Research · 2020 · 254 citations · Full text

Inhibition of Soluble Guanylate Cyclase by ODQ

Yunde Zhao, Philip E. Brandish, Marilena Di Valentin et al. · Biochemistry · 2000 · 230 citations

Modes of action of tunicamycin, liposidomycin B, and mureidomycin A: inhibition of phospho-N-acetylmuramyl-pentapeptide translocase from Escherichia coli

Philip E. Brandish, Ken‐ichi Kimura, M Inukai et al. · Antimicrobial Agents and Chemotherapy · 1996 · 200 citations · Full text

, , +18

Rows per page

1–5 of 28